Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins

Authors

Issam Zineh, University of Florida
Amber L. Beitelshees, University of FloridaFollow
Gregory J. Welder, University of Florida
Wei Hou, University of Florida
Nasser Chegini, University of Florida
Jun Wu, Washington University School of Medicine in St. Louis
Sharon Cresci, Washington University School of Medicine in St. LouisFollow
Michael A. Province, Washington University School of Medicine in St. Louis
John A. Spertus, Mid America Heart Institute, Kansas City

Journal

PLoS One

Publication Date

2008

Volume

3

Issue

9

Inclusive Pages

e3117

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0003117

Rights and Permissions

Zineh I, Beitelshees AL, Welder GJ, Hou W, Chegini N, et al. 2008 Epithelial Neutrophil-Activating Peptide (ENA-78), Acute Coronary Syndrome Prognosis, and Modulatory Effect of Statins. PLoS ONE 3(9): e3117. doi:10.1371/journal.pone.0003117

Recommended Citation

Zineh, Issam; Beitelshees, Amber L.; Welder, Gregory J.; Hou, Wei; Chegini, Nasser; Wu, Jun; Cresci, Sharon; Province, Michael A.; and Spertus, John A., "Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins." PLoS One. 3, 9. e3117. (2008).
https://digitalcommons.wustl.edu/open_access_pubs/798